What Happens to PSA After Radical Prostatectomy?
After radical prostatectomy, the PSA level is expected to fall to a very low or undetectable level because the prostate gland and seminal vesicles have been removed. Regular PSA blood tests are then used to monitor the outcome of surgery and look for any evidence that prostate cancer may still be present or return.
A detectable PSA result does not always provide an immediate answer. The value, timing, pattern over successive tests and findings from the final pathology report must all be considered together.
Why Is PSA Monitored After Surgery?
Prostate-specific antigen, or PSA, is a protein produced mainly by prostate tissue. Before treatment, PSA contributes to the assessment and monitoring of prostate cancer, although an elevated result can also occur for non-cancerous reasons.
Following radical prostatectomy, very little PSA-producing tissue should remain. This makes PSA particularly useful for monitoring patients after surgery. The purpose of follow-up testing is to confirm that PSA has fallen appropriately and to detect a persistent or rising level at an early stage. PSA monitoring is therefore an important part of follow-up after both open and robotic radical prostatectomy.
When Is the First PSA Test Performed?
The first postoperative PSA test is usually arranged several weeks after surgery. Testing immediately after the operation would not be helpful because PSA already present in the bloodstream requires time to disappear.
The precise timing varies between hospitals and individual treatment pathways. Your surgical team will explain when the first test should be performed and how subsequent results will be communicated.
The European Association of Urology states that PSA is expected to be undetectable approximately two months after radical prostatectomy.
What Should the PSA Level Be After Prostate Removal?
Following successful removal of the prostate, PSA should fall to a very low or undetectable level. The exact result reported depends partly on the laboratory and the sensitivity of the test used. Some laboratories use ultrasensitive PSA tests capable of measuring extremely small amounts of PSA. These tests may produce a numerical result even when the level is exceptionally low. A very small detectable value does not necessarily mean that clinically significant cancer is present. It must be interpreted in context rather than considered in isolation.
What Is a Persistent PSA?
Persistent PSA describes a PSA level that does not become appropriately low following surgery. Possible explanations include remaining benign prostate tissue, prostate cancer cells close to the surgical area or cancer that was already present elsewhere in the body. The significance depends on the PSA value, its subsequent behaviour and the characteristics of the original cancer.
If PSA remains measurable, the next step is not automatically further treatment. The result should be reviewed alongside the final pathology, including the tumour stage, Grade Group, lymph-node findings and surgical margins. Repeating the PSA test may help establish whether the level is stable, falling or rising.
What Does a Rising PSA Mean?
A PSA that initially becomes undetectable and subsequently begins to rise may indicate biochemical recurrence. Biochemical recurrence means that PSA suggests renewed cancer activity before recurrence necessarily becomes visible on a scan or causes symptoms. It does not automatically mean that the cancer has spread widely or that immediate treatment is always required.
Doctors usually consider the pattern across successive results rather than making a major decision from one isolated measurement. The speed of the rise, known as PSA doubling time, can also provide useful information about the likely behaviour of the disease.
Does a Detectable PSA Always Require a Scan?
Not necessarily. Imaging is not routinely required when PSA remains undetectable and the patient has no concerning symptoms. If PSA is persistently detectable or rising, imaging may be considered when its result could influence treatment. The type and timing of imaging depend on the PSA level, the rate of change, the original pathology and the treatment options being considered.
Modern PSMA PET/CT imaging may identify prostate cancer at relatively low PSA levels, but even sensitive scans may not show an abnormality when the amount of disease is very small. A negative scan therefore does not always exclude microscopic recurrence.
What Treatment May Be Considered If PSA Rises?
Treatment depends on the individual clinical circumstances. For some men, continued PSA monitoring may initially be appropriate. For others, additional treatment may be discussed. Options can include radiotherapy to the prostate bed, radiotherapy to selected lymph nodes, hormone treatment or a combination of treatments. Occasionally, imaging identifies a specific area that can be considered separately.
The potential benefit of additional treatment must be balanced against possible side effects. Decisions should be made after reviewing the PSA pattern, pathology, imaging, general health and personal priorities.
How Often Will PSA Be Checked?
PSA is checked regularly after radical prostatectomy, with closer monitoring generally undertaken during the first years following treatment. If results remain stable and undetectable, the interval between tests may become longer. The exact schedule varies according to the pathology results, the estimated risk of recurrence and local follow-up arrangements. The European Association of Urology describes PSA testing every six months for three years and annually thereafter as a commonly used approach, while recognising that follow-up should be individualised.
Long-term monitoring remains important because PSA recurrence can occasionally occur several years after treatment.
What Other Follow-Up Is Required?
PSA is only one part of postoperative care. Follow-up should also address recovery of urinary control, erectile function, general wellbeing and any complications related to treatment. Patients should know when their next PSA test is due, who will review the result and whom they should contact if they develop new symptoms or have concerns about their recovery.
When Should I Discuss My PSA Result With a Specialist?
Specialist assessment may be helpful if:
PSA has not fallen as expected after surgery
A previously undetectable PSA has become measurable
PSA is rising on repeated tests
You are uncertain about the meaning of an ultrasensitive PSA result
Your pathology report identified adverse features
Further imaging or treatment has been proposed
You would like a second opinion about postoperative management
Interpretation should be based on the complete clinical picture rather than the PSA number alone.
The Bottom Line
PSA should normally fall to a very low or undetectable level after radical prostatectomy. Regular testing is used to confirm the response to surgery and identify a persistent or rising PSA. A single low but detectable result does not necessarily establish recurrence or mean that immediate treatment is required. The PSA trend, final pathology, timing after surgery and individual risk factors must be reviewed together.
Arrange a Consultation
If you would like to discuss a PSA result following prostate cancer surgery or obtain a second opinion about further investigation or treatment, Dr Carlo Bravi offers private urology consultations in Northampton and London.
A consultation provides an opportunity to review your PSA history, pathology, imaging and available treatment options in the context of your individual circumstances.
This article provides general information and does not replace individual medical advice.
Comments